Natpar (parathyroid hormone) 25, 50, 75 and 100 micrograms/dose powder and solvent for solution for injection: end of supply due to marketing cessation (discontinuation).

Due to unresolved manufacturing challenges with Natpar, manufacturing of the 100mcg dose was discontinued in 2022 and manufacturing of all other strengths was discontinued globally at the end of 2024. The company has continued to supply any remaining stock where available but the distribution of all packages (with the exception of the 100 mcg strength, unavailable since October 2022) will presumably cease starting from 15/05/2026.

Published on: 06 February 2026